Fresenius Medical Care AG (FMS) Long-Term Investments (2009 - 2025)

Fresenius Medical Care AG (FMS) has 17 years of Long-Term Investments data on file, last reported at $772.5 million in Q4 2025.

• In Q4 2025, Long-Term Investments rose 16.45% year-over-year to $772.5 million; the TTM figure through Dec 2025 stood at $772.5 million (up 16.45% YoY), while the FY2025 annual figure was $772.5 million, up 16.45% from the prior year.
• Long-Term Investments fell to $772.5 million in Q4 2025, from $878.2 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $900.2 million in Q4 2021 and bottomed at $663.4 million in Q4 2024.
• A 5-year average of $788.5 million and a median of $779.0 million in 2022 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2024 — Long-Term Investments fell 21.9% — and 2025, when it advanced 16.45%.
• Year by year, Long-Term Investments stood at $900.2 million in 2021, then fell by 12.31% to $789.4 million in 2022, then dropped by 12.37% to $691.8 million in 2023, then decreased by 4.1% to $663.4 million in 2024, then advanced by 16.45% to $772.5 million in 2025.
• The last three Long-Term Investments figures came in at $772.5 million (Q4 2025), $878.2 million (Q3 2025), and $804.5 million (Q2 2025), per Business Quant data.

Peer Comparison